Furthermore, to evaluate the biological function of MLL2 in ESCC, we applied the latest gene editing technique CRISPR/Cas9 to knockout MLL2 in ESCC cell line Eca109. This evidence concerns the gene KMT2D and esophageal squamous cell carcinoma.